A comprehensive view of Endocrine / Hormonal Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca acquires French biotech Amolyt Pharma for US$800.0M to expand into rare endocrinology field; deal includes eneboparatide, a Phase 3 candidate drug aimed at potentially reducing dependence on supplements in hypoparathyroidism patients

Plastic food packaging contains thousands of hormone-mimicking chemicals that can leach into food, according to new study published in Environmental Science & Technology; researchers found most potent effects from extracts of PU, PVC and LDPE

France fines companies, organizations in the canning sector €19.5M for violating competition rules over use of BPA in packaging, which is claimed to be an endocrine disruptor; companies include Unilever, Bonduelle, General Mills, Ardagh, Crown, Massilly

WGSN lists 'hormonal skin care' among big beauty trends for 2024, highlighting links between hormones and acne, impacts of menopause and menstruation; notable brands expanding the category are NAYDAYA, Living M and Faace

Mount Sinai researchers find testosterone therapy safer than previously thought for transmasculine people; increased red blood cell volume changes are small and unlikely to be clinically significant

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count